Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: CRV039
MIFTS: 52

Cervicitis

Categories: Reproductive diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Cervicitis

About this section

MalaCards integrated aliases for Cervicitis:

Name: Cervicitis 12 54 15
Uterine Cervicitis 44 71

Classifications:

MalaCards categories:
Anatomical: Reproductive diseases
See all MalaCards categories (disease lists)
ICD10: 32


External Ids:

Disease Ontology 12 DOID:2568
ICD9CM 34 616.0
MeSH 44 D002575
NCIt 50 C26716
SNOMED-CT 67 198199009 237081003
ICD10 32 N72
UMLS 71 C0007860 C0007861
Sources

Summaries for Cervicitis

About this section
Disease Ontology : 12 A cervix disease that is characterized by inflammation of the cervix.

MalaCards based summary : Cervicitis, also known as uterine cervicitis, is related to chronic cervicitis and acute gonococcal cervicitis. An important gene associated with Cervicitis is TLR4 (Toll Like Receptor 4), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Azithromycin and Lymecycline have been mentioned in the context of this disorder. Affiliated tissues include cervix, spinal cord and lymph node, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and Synthetic lethal with MLN4924 (a NAE inhibitor)

Wikipedia : 74 Cervicitis is inflammation of the uterine cervix. Cervicitis in women has many features in common with... more...

Sources

Related Diseases for Cervicitis

About this section

Diseases in the Cervicitis family:

Acute Cervicitis Chronic Cervicitis

Diseases related to Cervicitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 752)
# Related Disease Score Top Affiliating Genes
1 chronic cervicitis 32.2 SERPIND1 GP6 GP5 CDKN2A
2 acute gonococcal cervicitis 32.0 IL6 IL10 CXCL8
3 acute cervicitis 32.0 SERPIND1 IL10 CXCL8
4 pelvic inflammatory disease 31.0 TLR4 IL2 HSPD1
5 cervix uteri carcinoma in situ 30.4 SERPIND1 GP6 GP5 CDKN2A
6 vulvovaginitis 30.2 IL10 HSPD1 CXCL8
7 salpingitis 30.2 TNF IL6 HSPD1 CD4
8 endometritis 30.0 TNF TLR4 IL6 IL1B CXCL8
9 chlamydia 29.9 TNF TLR4 IL6 IL1B IL10 HSPD1
10 oral candidiasis 29.9 DEFB4A DEFB103B CXCL8 CD4
11 genital herpes 29.7 IL10 CD8A CD4
12 cystitis 29.4 TNF TLR4 IL6 IL2 CXCL8
13 vaginitis 29.4 TNF IL6 IL1B IL10 DEFB4A CXCL8
14 bacterial vaginosis 29.4 TNF TLR4 IL6 IL1B IL10 DEFB4A
15 conjunctivitis 29.4 TNF IL6 IL2 IL10 CXCL8
16 vaginal discharge 29.3 TNF IL6 IL1B IL10 CXCL8 CD4
17 measles 29.1 TNF TLR9 TLR4 IL6 IL2RA IL2
18 disseminated intravascular coagulation 29.1 TNF IL6 IL10
19 urethral syndrome 29.1 TNF IL6 IL1B CXCL8 CD4
20 pulmonary tuberculosis 29.0 TNF IL6 IL2RA IL2 IL10
21 preterm premature rupture of the membranes 28.7 TNF TLR4 IL6 IL1B IL10 CXCL8
22 amebiasis 28.7 TNF IL1B IL10 CXCL8 CD4
23 chorioamnionitis 28.7 TNF TLR4 IL6 IL1B IL10 DEFB103B
24 anogenital venereal wart 28.7 TLR9 TLR4 IL2 GP6 GP5 CDKN2A
25 erythema nodosum 28.6 TNF IL6 IL1B IL10 CXCL8
26 candidiasis 28.5 TNF TLR4 IL6 IL2 IL1B IL10
27 duodenal ulcer 28.5 TNF TLR4 IL6 IL1B IL10 CXCL8
28 peritonitis 28.5 TNF TLR4 IL6 IL1B IL10 CXCL8
29 trichomoniasis 28.5 TNF IL6 IL2 IL1B IL10 CXCL8
30 aphthous stomatitis 28.3 TNF TLR4 IL6 IL2 IL1B IL10
31 urethritis 28.3 TNF TLR4 MAPK1IP1L IL6 IL1B IL10
32 diarrhea 28.3 TNF TLR4 IL6 IL2 IL1B IL10
33 stomatitis 28.2 TNF IL6 IL2 IL1B IL10 CXCL8
34 tonsillitis 28.2 TNF TLR9 TLR4 IL6 IL2 IL1B
35 exanthem 27.7 TNF IL6 IL2 IL1B IL10 CXCL8
36 cystic fibrosis 27.5 TNF TLR4 IL6 IL2 IL1B IL10
37 bacterial infectious disease 27.5 TNF TLR9 TLR4 IL6 IL1B IL10
38 immune deficiency disease 27.2 TNF TLR9 MIR21 IL6 IL2RA IL2
39 chronic gonorrhea of cervix 11.4
40 endocervicitis 11.0
41 cervix disease 10.9
42 herpes simplex 10.4
43 pilonidal sinus 10.4 IL2RA CD4
44 adenohypophysitis 10.3 IL2RA CD4
45 cervical cancer 10.3
46 mycobacterium fortuitum 10.3 HSPD1 CXCL8
47 autoimmune atherosclerosis 10.3 HSPD1 CD4
48 hypersplenism 10.3 TLR4 IL2RA CD4
49 inverted follicular keratosis 10.3 GP6 GP5
50 folliculitis 10.3 IL2RA DEFB4A CD4

Graphical network of the top 20 diseases related to Cervicitis:



Diseases related to Cervicitis
Sources

Symptoms & Phenotypes for Cervicitis

About this section

GenomeRNAi Phenotypes related to Cervicitis according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.44 CDKN2A CXCL8 IL10 IL1B IL2RA TNF
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.44 CDKN2A CXCL8 IL10 IL1B IL2 IL2RA

MGI Mouse Phenotypes related to Cervicitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.21 CD4 CD8A CDKN2A GP6 HSPD1 IL10
2 immune system MP:0005387 10.1 CD4 CD8A CDKN2A GP6 IL10 IL1B
3 digestive/alimentary MP:0005381 10.06 CD4 CDKN2A IL10 IL2 IL2RA IL6
4 mortality/aging MP:0010768 10 CD4 CD8A CDKN2A GP6 HSPD1 IL10
5 integument MP:0010771 9.96 CD4 CD8A CDKN2A GP6 HSPD1 IL10
6 neoplasm MP:0002006 9.5 CDKN2A IL10 IL1B IL2 IL6 TLR4
7 respiratory system MP:0005388 9.23 CDKN2A HSPD1 IL10 IL2 IL2RA IL6
Sources

Drugs & Therapeutics for Cervicitis

About this section

Drugs for Cervicitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 609)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azithromycin Approved Phase 4 83905-01-5 55185 447043
2
Lymecycline Approved, Investigational Phase 4 992-21-2 5280963
3
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
4
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
5
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
6
Dienogest Approved Phase 4 65928-58-7
7
Remifentanil Approved Phase 4 132875-61-7 60815
8
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
9
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
10
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
11
Racepinephrine Approved Phase 4 329-65-7 838
12
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
13
Chloroprocaine Approved Phase 4 133-16-4 8612
14
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
15
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
16
Silicon Approved, Investigational Phase 4 7440-21-3 4082203
17
Meperidine Approved Phase 4 57-42-1 4058
18
Ibuprofen Approved Phase 4 15687-27-1 3672
19
Warfarin Approved Phase 4 81-81-2 6691 54678486
20
Pregabalin Approved, Investigational Phase 4 148553-50-8 5486971
21
Acenocoumarol Approved, Investigational Phase 4 152-72-7 9052 54676537
22
Phenprocoumon Approved, Investigational Phase 4 435-97-2 9908 54680692
23
Vitamin K1 Approved, Investigational Phase 4 84-80-0 5284607
24
Isosorbide Dinitrate Approved, Investigational Phase 4 87-33-2 6883
25
AT-101 Approved, Investigational Phase 4 90141-22-3, 652-67-5 12597
26
Aluminum hydroxide Approved, Investigational Phase 4 21645-51-2
27
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
28
Lorazepam Approved Phase 4 846-49-1 3958
29
Lactitol Approved, Investigational Phase 4 585-86-4 157355
30
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
31
Xylometazoline Approved, Investigational Phase 4 526-36-3 5709
32
Leuprolide Approved, Investigational Phase 4 53714-56-0 3911 657181
33
Norethindrone Approved Phase 4 68-22-4 6230
34
Tizanidine Approved, Investigational Phase 4 51322-75-9 5487
35
Diazepam Approved, Illicit, Investigational, Vet_approved Phase 4 439-14-5 3016
36
Polihexanide Approved, Investigational Phase 4 28757-47-3
37
Mepivacaine Approved, Vet_approved Phase 4 96-88-8 4062
38
Bethanechol Approved Phase 4 674-38-4 2370
39
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
40
tannic acid Approved Phase 4 1401-55-4
41
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 68602 5311068
42
Trazodone Approved, Investigational Phase 4 19794-93-5 5533
43
Nitroglycerin Approved, Investigational Phase 4 55-63-0 4510
44
Prilocaine Approved Phase 4 721-50-6 4906
45
Oxytocin Approved, Vet_approved Phase 4 50-56-6 439302 53477758
46
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
47
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
48
Dinoprostone Approved Phase 4 363-24-6 5280360
49
Bupivacaine Approved, Investigational Phase 4 38396-39-3, 2180-92-9 2474
50
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033

Interventional clinical trials:

(show top 50) (show all 2928)
# Name Status NCT ID Phase Drugs
1 Study of Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Antibiotic Treatment Unknown status NCT01661985 Phase 4 Azithromycin;Doxycycline;lymecycline
2 Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Sonographic Short Cervix and History of Preterm Labor and/or Midtrimester Miscarriage Unknown status NCT02673359 Phase 4 Progesterone
3 The Effect of Adding Vaginal Evening Primrose Oil to Misoprostol During Induction of Second-trimester Missed Miscarriage; a Randomized Controlled Trial Unknown status NCT03584698 Phase 4 Misoprostol 100Mcg Tab;Evening Primrose Oil 1000 MG
4 Dilapan vs Misoprostol for Cervical Ripening [COMRED - Comparison of Misoprostol Ripening Efficacy With Dilapan] Unknown status NCT03670836 Phase 4 Misoprostol
5 Cervical Cerclage for Preventing Spontaneous Preterm Birth in Singleton Pregnancies Without Prior Spontaneous Preterm Birth and With Short Transvaginal Ultrasound Cervical Length Unknown status NCT02746900 Phase 4
6 A Randomized Controlled Trial Evaluating the Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) in Patients With Cervical Intraepithelial Neoplasia or Cervical Cancer Unknown status NCT02629510 Phase 4 Tachosil
7 Evaluation of the Postoperative Analgesic Efficacy of Bilateral Superficial Cervical Block for Thyroidectomy and Mini Incision Under General Balanced Anesthesia: a Randomized, Triple Masked, Placebo Controlled Trial. Unknown status NCT01171885 Phase 4 0.9% saline;Ropivacaine;Ropivacaine
8 Efficacy of Induction of Labor on Term Using a Double Balloon Catheter Compared to Dinoprostone Vaginal-insert - a Multicenter Randomized Controlled Trial Unknown status NCT01720394 Phase 4 Dinoprostone
9 A Post-marketing Evaluation of a Compound Traditional Chinese Herbal Medicine, Qishe Pill, on Cervical Radiculopathy Unknown status NCT01875562 Phase 4 Qishe Pill
10 A Prospective, Open, Randomized, Controlled Clinical Study to Evaluate the Efficacy and Safety of PEG-rhG-CSF in Reducing Neutropenia in Patients With Cervical Cancer Unknown status NCT03206684 Phase 4 PEG-rhG-CSF;rhG-CSF
11 Same-day Cervical Preparation With Misoprostol Before Hysteroscopy: a Randomized Trial of Different Routes of Administration Unknown status NCT02474433 Phase 4 Misoprostol (Cytotec)
12 Can Mindfulness Meditation Limit the Progression and/or Increase the Remission of Cervical Dysplasia? Unknown status NCT00842738 Phase 4
13 Comparison of Intravaginal Misoprostol and Dinoprostol for the Purpose of Cervical Ripening Before Diagnostic Hysteroscopy in the Women at the Reproductive Age:RANDOMÄ°SED,CONTROLLED PROSPECTÄ°VE TRÄ°AL Unknown status NCT01620814 Phase 4 Dinoprostone;misoprostol;control
14 Comparison Between Two Strategies of Induction in Case of Unfavourable Cervix After 12 Hours of Premature Rupture of Membranes (PROM) at Term: Cook Cervical Ripening + Oxytocine From 6 Hours Versus Dinoprostone Vaginal Insert Unknown status NCT03310333 Phase 4 Propess® (dinoprostone)
15 Effect Of Intra-muscular Administration of Dexamethasone on the Duration of Induction of Labour in Primigravida Post-term Pregnancy. Unknown status NCT02508402 Phase 4 Dexamethasone;Placebo
16 Efficacy and Safety of Multimodal Analgesia Used in Patients With Microvascular Decompression Unknown status NCT03152955 Phase 4 Ketamine;ondansetron;Sufentanil
17 Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women Unknown status NCT02440750 Phase 4 Dienogest;Ulipristal acetate
18 Comparative Study Between ICSI Results in Transvaginal Ultrasound Guided Embryo Transfer and Transabdominal Ultrasound Guided Embryo Transfer Unknown status NCT03683043 Phase 4 Long GnRH agonist protocol
19 Anesthesia Induction With Propofol or Sevoflurane in Patients Undergoing Fiberoptic Intubation for Cervical Myelopathy: Effects on Heamodynamics Unknown status NCT01052337 Phase 4 anaesthetics: sevofluorane
20 The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients Unknown status NCT01664013 Phase 4 Nuronox
21 Cervical Ripening at Term With Prostaglandin E2 Tablets Versus Foley Catheter: a Randomized Controlled Trial Unknown status NCT02486679 Phase 4 Prostin (PGE2) tablets
22 Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction: Randomized Clinical Trial Unknown status NCT02902653 Phase 4 Oral misoprostol;Vaginal misoprostol;Vaginal dinoprostone
23 Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index in Anterior Cervical Decompression and Fusion With Internal Fixation Unknown status NCT02890186 Phase 4
24 Different Routes of Misoprostol for Same-day Cervical Preparation Prior to First Trimester Surgical Abortion: a Randomized Controlled Trial Unknown status NCT02480543 Phase 4 Misoprostol (cytotec)
25 Clinical and Radiographic Outcomes of BIO4 Bone Matrix in Patients Undergoing 1 or 2-Level Anterior Cervical Discectomy and Fusion Surgery Completed NCT03077204 Phase 4
26 A Randomized, Prospective, Double-Blind Controlled Evaluation of the Effectiveness of Cervical and Thoracic Interlaminar Epidural Injections in Thoracic and Cervical Disc Herniation, Discogenic Pain, and Post-Cervical Laminectomy Syndrome Completed NCT01071369 Phase 4 Xylocaine;Xylocaine and Celestone
27 Botulinum Toxin A for the Treatment of Cervical/Shoulder Pain Following Acute Spinal Cord Injury. Completed NCT00320281 Phase 4 botulinum toxin A
28 A Randomized Controlled Clinical Trial of Intrathecal Chloroprocaine vs. Bupivacaine for Cervical Cerclage Completed NCT03305575 Phase 4 Chloroprocaine;Bupivacaine
29 Perception of Discomfort and Psychosocial Difficulties in People With Diagnosis of Fibromyalgia and Predominant Neck Pain Completed NCT02078791 Phase 4 Botox infiltration
30 Study of Pain Control With Hormonal IUS Insertion (SOPHI Study) Completed NCT02352714 Phase 4 Paracervical Nerve Block;Sham Paracervical Block
31 The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral Misoprostol Completed NCT00886860 Phase 4 misoprostol;misoprostol
32 A Prospective Randomized Controlled Trial of Standardized C7-T1 Epidural Steroid Injections Versus Targeted Injection Via Cervical Epidural Catheter for the Treatment of Cervical Radicular Pain Completed NCT02095197 Phase 4 Triamcinolone 80mg
33 The Effect of Intracervical Lidocaine Injection Versus Topical Lidocaine Gel on the Pain Experienced by Patients Undergoing Tenaculum Application to the Cervix at the Time of an Office Gynecologic Procedure Completed NCT01421641 Phase 4 Intracervical Lidocaine Injection;Topical Lidocaine Gel
34 Prospective, Single-arm, Multicenter Trial to Investigate the Efficacy and Safety of NT 201 and the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Patients With Cervical Dystonia Completed NCT00541905 Phase 4 NT 201
35 Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls Completed NCT01173900 Phase 4
36 Open Labelled Study of Pregabalin in the Treatment of Neuropathic Pain in Cervical Myeloradiculopathy (Pregabalin and Radicular Pain Study (PARPS)) Completed NCT01061697 Phase 4 Pregabalin
37 Influence of the Concentration of the Local Anesthetic Ropivacaine on the Quality of a Ultrasound Guided Block of the Regio Collis Lateralis for Carotid Endarterectomy: a Prospective, Randomized and Controlled Trail Completed NCT01759940 Phase 4 ropivacaine 0,375%;ropivacaine 0,75%
38 Management of Cervical Intraepithelial Neoplasia Grade 2 Completed NCT00733109 Phase 4
39 Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD Completed NCT02046460 Phase 4 Acetylsalicylic acid;Vitamin K antagonist
40 The Effect Site Concentration of Remifentanil for Conscious Sedation During Awake Nasotracheal Fiberoptic Intubation Completed NCT01052324 Phase 4 Remifentanil
41 Determining the ED90 for Intrathecal 3% Chloroprocaine for Elective Cervical Cerclage Surgery Completed NCT03805438 Phase 4 Chloroprocaine Hcl 3% Inj
42 An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution in Patients With Cervical Dystonia Completed NCT00702754 Phase 4
43 Evaluation of the Safety of C-Spine Clearance by Emergency Department Triage Nurses (Phase IV) Completed NCT01353352 Phase 4
44 Comparison Between Vaginal and Sublingual Misoprostol 50 µg for Cervical Ripening Prior to Induction of Labor: Randomized Clinical Trial Completed NCT02732522 Phase 4 Sublingual misoprostol;Vaginal misoprostol
45 Assessment of Use of Misoprostol to Facilitate the Insertion of Intrauterine Contraceptives After Failure of Insertion. A Randomized Double-blind Clinical Trial Completed NCT01754649 Phase 4 Misoprostol
46 Pre-injection, Multi-channel EMG Mapping to Optimize Botulinum Toxin Type A Efficacy in Cervical Dystonia. Completed NCT00773253 Phase 4 Botulinum toxin A
47 Synergistic Effects of Neurotoxin and Physical Therapy Completed NCT02177617 Phase 4 Botox injection
48 Double Balloon Catheter Versus Vaginal PGE2 for Pre-induction Cervical Ripening: a Randomized Study. Completed NCT01170819 Phase 4 Dinoprostone 10 mg controlled-release vaginal insert
49 Immunogenicity Of A Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, And 18) L1 Virus-Like Particle Vaccine In Male And Female Adolescent Transplant Recipients. Completed NCT01101750 Phase 4
50 A Phase IV Open-Label, Descriptive Study to Evaluate the Safety and Effectiveness on the Incidence of HPV 6, 11, 16 and 18 Related CIN 2/3 or Worse of the Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in 16- to 26-Year-Old Japanese Women Completed NCT01544478 Phase 4

Search NIH Clinical Center for Cervicitis

Cochrane evidence based reviews: uterine cervicitis

Sources

Genetic Tests for Cervicitis

About this section
Sources

Anatomical Context for Cervicitis

About this section

MalaCards organs/tissues related to Cervicitis:

40
Cervix, Spinal Cord, Lymph Node, Bone, Thyroid, Placenta, Eye
Sources

Publications for Cervicitis

About this section

Articles related to Cervicitis:

(show top 50) (show all 1963)
# Title Authors PMID Year
1
Human antibody responses to a Chlamydia-secreted protease factor. 54 61
15557641 2004
2
Ainsliaea fragrans champ. Extract prevents cervicitis in BALB/c mice and regulates MyD88-NF-κB signaling pathway in MALP-2-stimulated RAW264.7 cells. 61
33309583 2021
3
Liquid-based cytology of amoebic cervicitis clinically mimicking cervical cancer. 61
33128844 2021
4
The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer. 61
32514824 2021
5
Detection of DKK-1 gene methylation in exfoliated cells of cervical squamous cell carcinoma and its relationship with high risk HPV infection. 61
33547934 2021
6
The Value and Clinical Significance of ZNF582 Gene Methylation in the Diagnosis of Cervical Cancer. 61
33488095 2021
7
The research progresses and future prospects of Tetrastigma hemsleyanum Diels et Gilg: A valuable Chinese herbal medicine. 61
33465440 2021
8
Proteome wide vaccine targets prioritization and designing of antigenic vaccine candidate to trigger the host immune response against the Mycoplasma genitalium infection. 61
33524568 2021
9
[The role of herpesviruses in development of diseases of the urogenital tract and infertility in women]. 61
33533228 2021
10
Application Value of Detection of High-Risk HPV Infection in Early Cervical Cancer Patients in Disease Diagnosis and Prognosis Evaluation. 61
33337824 2020
11
Russell Body Cervicitis-rare But Relevant. 61
33417633 2020
12
Dual modal fluorescent colposcope combined with near-infrared fluorescent dye TMTP1-PEG4-ICG to detect cervical lesions. 61
33408984 2020
13
Alternative conformation of the C-domain of the P140 protein from Mycoplasma genitalium. 61
33135669 2020
14
Prevalence and incidence of Mycoplasma genitalium in a cohort of HIV-infected and HIV-uninfected pregnant women in Cape Town, South Africa. 61
31932358 2020
15
Co-infection between genotypes of the human papillomavirus and Chlamydia trachomatis in Mexican women. 61
32998641 2020
16
Re-evaluation of Negative Cone Biopsy Results with Ki-67 and p16 Immunostaining following Positive Cervical Biopsy. 61
33281264 2020
17
Photodetection and Safety of 5-Aminolevulinic Acid-Induced Porphyrin in Patients With Cervical Intraepithelial Neoplasia. 61
33161594 2020
18
Single-Inclusion Kinetics of Chlamydia trachomatis Development. 61
33051378 2020
19
Impact of cervicitis on performance of cervical cancer screening using HRHPV testing and visual evaluation in women living with HIV in Botswana. 61
32449207 2020
20
Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade. 61
33020921 2020
21
Cytological, Colposcopic and Pathohistological Correlation of HSIL and ASC H Findings. 61
33424094 2020
22
An Unusual Case of Extra-Enteric Blastocystosis in the Uterine Cervix. 61
33202510 2020
23
The impact of cryotherapy for symptomatic cervical ectropion on female sexual function and quality of life. 61
33073648 2020
24
Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening. 61
32680634 2020
25
Prevalence of Chlamydia trachomatis in an asymptomatic female population attending cervical cytology services of three healthcare centers in Medellín, Colombia 61
33030832 2020
26
Neutrophil interactions with the sexually transmitted parasite Trichomonas vaginalis: implications for immunity and pathogenesis. 61
32873151 2020
27
Association between APOBEC3s and HPV16 E2 gene hypermutation in Uygur females with cervical cancer. 61
32724418 2020
28
Associations between the expression of SCCA, MTA1, P16, Ki-67 and the infection of high-risk HPV in cervical lesions. 61
32566016 2020
29
Streptococcus agalactiae-Induced Soft Tissue Infection in a Nonpregnant Adult After a Gynecological Procedure. 61
32680980 2020
30
Structure and mechanism of the Nap adhesion complex from the human pathogen Mycoplasma genitalium. 61
32513917 2020
31
Brucellar reproductive system injury: A retrospective study of 22 cases and review of the literature. 61
32552113 2020
32
Reconsidering Presumptive Neisseria gonorrhoeae Treatment For Women With Cervicitis. 61
32149957 2020
33
Cervicitis: Balancing the Goals of Empiric Therapy and Antimicrobial Stewardship to Improve Women's Health. 61
32421298 2020
34
Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis. 61
32534649 2020
35
The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae. 61
32119845 2020
36
Characteristics of Mycoplasma genitalium Urogenital Infections in a Diverse Patient Sample from the United States: Results from the Aptima Mycoplasma genitalium Evaluation Study (AMES). 61
32321783 2020
37
Relevance research between the expression of p16INK4a , Notch1, and hTERC genes: The development of HPV16-positive cervical cancer. 61
31976596 2020
38
The Role of CADM1 and MAL Promoter Methylation in Inflammation and Cervical Intraepithelial Neoplasia. 61
32311274 2020
39
Formulation, Physiochemical, and Microbial Assay of Henna Oil Vaginal Suppository Formulated with Polyethylene Glycol Bases. 61
32546887 2020
40
The Chinese herbal prescription JZ-1 induces autophagy to protect against herpes simplex Virus-2 in human vaginal epithelial cells by inhibiting the PI3K/Akt/mTOR pathway. 61
32088246 2020
41
p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening. 61
32410798 2020
42
A profile of the cobas® TV/ MG test for the detection of Trichomonas vaginalis and Mycoplasma genitalium. 61
31917618 2020
43
A case of Mycoplasma genitalium possible resistance in a woman. 61
32258345 2020
44
Uterine cervix as a fundamental part of the pathogenesis of pregnancy loss associated with ascending placentitis in mares. 61
31732164 2020
45
Description of Referrals for Colposcopy in a Hospital in Brazil. 61
32232821 2020
46
Positive staining of the immunoligand B7-H6 in abnormal/transformed keratinocytes consistently accompanies the progression of cervical cancer. 61
32138659 2020
47
Mycoplasma genitalium, a stealth female reproductive tract. 61
31522281 2020
48
Mycoplasma genitalium prevalence in Welsh sexual health patients: Low antimicrobial resistance markers and no association of symptoms to bacterial load. 61
31756372 2020
49
Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for Azithromycin. 61
30963175 2020
50
Mycoplasma genitalium: A Review. 61
31329090 2020
Sources

Variations for Cervicitis

About this section
Sources

Expression for Cervicitis

About this section
Search GEO for disease gene expression data for Cervicitis.
Sources

Pathways for Cervicitis

About this section

Pathways related to Cervicitis according to GeneCards Suite gene sharing:

(show top 50) (show all 73)
# Super pathways Score Top Affiliating Genes
1
Innate Immune System 65
Show member pathways
 14.11 TNF TLR9 TLR4 IL6 IL2RA IL2
2
ERK Signaling 63
Show member pathways
 13.87 TNF IL6 IL2RA IL2 IL1B IL10
3
PEDF Induced Signaling 63
Show member pathways
 13.74 TNF TLR4 IL6 IL2RA IL2 IL1B
4
TGF-Beta Pathway 63
Show member pathways
 13.59 TNF IL6 IL2RA IL2 IL1B IL10
5
Akt Signaling 63
Show member pathways
 13.51 TNF TLR9 TLR4 IL6 IL2RA IL2
6
Cytokine Signaling in Immune system 65
Show member pathways
 13.44 TNF IL6 IL2RA IL2 IL1B IL10
7
PAK Pathway 63
Show member pathways
 13.38 TNF IL6 IL2RA IL2 IL1B IL10
8
Toll-like Receptor Signaling Pathway 36 1
Show member pathways
 13.17 TNF TLR9 TLR4 IL6 IL2 IL1B
9
Human cytomegalovirus infection 36
Show member pathways
 13.04 TNF TLR4 IL6 IL1B CXCL8 CDKN2A
10
Measles 36
Show member pathways
 12.93 TNF TLR9 TLR4 IL6 IL2RA IL2
11
Allograft rejection 36 1
Show member pathways
 12.9 TNF IL6 IL2RA IL2 IL1B IL10
12
Salmonella infection (KEGG) 36
Show member pathways
 12.84 TNF TLR9 TLR4 IL6 IL1B CXCL8
13
Toll-Like receptor Signaling Pathways 64
Show member pathways
 12.82 TNF TLR9 TLR4 IL6 IL1B CXCL8
14
NF-KappaB Family Pathway 63
Show member pathways
 12.8 TNF TLR9 TLR4 IL6 IL2 IL1B
15
Th17 cell differentiation 36
Show member pathways
 12.72 TNF TLR4 IL6 IL2RA IL2 IL1B
16
Immune response NFAT in immune response 23
Show member pathways
 12.7 TNF IL2RA IL2 IL10 CD4
17
Immune response IL-23 signaling pathway 23
Show member pathways
 12.7 TNF IL6 IL2 IL1B IL10 CD4
18
NF-kappaB Signaling 4
12.69 TNF TLR9 IL2RA IL2 IL1B IL10
19
T cell receptor signaling pathway 36
Show member pathways
 12.67 TNF TLR9 TLR4 IL6 IL2 IL1B
20
Human T-cell leukemia virus 1 infection 36
12.47 TNF IL6 IL2RA IL2 CDKN2A CD4
21
Chemokine Superfamily Pathway: Human/Mouse Ligand-Receptor Interactions 64
Show member pathways
 12.46 TNF IL6 IL2RA IL2 IL10 CXCL8
22
IL-17 Family Signaling Pathways 64
Show member pathways
 12.44 TNF IL6 IL1B DEFB4A CXCL8
23
Toll Comparative Pathway 63
Show member pathways
 12.42 TNF TLR4 IL6 IL1B CXCL8
24
Immune response IFN alpha/beta signaling pathway 23
Show member pathways
 12.39 TNF IL6 IL2RA IL2 IL1B IL10
25
Folate Metabolism 1
Show member pathways
 12.38 TNF IL6 IL2 IL1B
26
Diseases associated with the TLR signaling cascade 65
Show member pathways
 12.37 TNF TLR9 TLR4 IL6 CXCL8
27
NOD-like receptor signaling pathway 36
12.36 TNF TLR4 IL6 IL1B DEFB4A DEFB103B
28
Tuberculosis 36
12.35 TNF TLR9 TLR4 IL6 IL1B IL10
29
C-type lectin receptor signaling pathway 36
Show member pathways
 12.34 TNF TLR9 IL6 IL2 IL1B IL10
30
Toxoplasmosis 36
Show member pathways
 12.32 TNF TLR4 IL1B IL10
31
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways 1
12.3 TNF IL6 IL1B IL10 HSPD1 CXCL8
32
Bacterial infections in CF airways 23
Show member pathways
 12.3 TNF TLR9 TLR4 IL6 IL1B DEFB4A
33
Colorectal Cancer Metastasis 63
12.26 TNF TLR9 TLR4 IL6
34
MAPK Pathway 70
Show member pathways
 12.16 TLR9 TLR4 IL2RA IL2 IL1B
35
Spinal Cord Injury 1
12.15 TNF TLR4 IL6 IL2 IL1B CXCL8
36
Interleukin-4 and 13 signaling 65
12.12 TNF IL6 IL1B IL10 CXCL8
37
IL12-mediated signaling events 1
Show member pathways
 12.12 IL2RA IL2 IL1B CD8A CD4
38
Amoebiasis 36
12.08 TNF TLR4 IL6 IL1B IL10 CXCL8
39
Senescence and Autophagy in Cancer 1
12.05 IL6 IL1B CXCL8 CDKN2A
40
NF-kappa B signaling pathway 36
12.04 TNF TLR4 IL1B CXCL8
41
AGE-RAGE signaling pathway in diabetic complications 36
12.01 TNF IL6 IL1B CXCL8
42
Rheumatoid arthritis 36
12.01 TNF TLR4 IL6 IL1B CXCL8
43
Th17 Differentiation Pathway 64
Show member pathways
 12 TLR9 TLR4 IL6 IL1B CD4
44
Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers 64
11.99 TNF IL6 IL2RA IL2 IL10 GP5
45
Hematopoietic cell lineage 36
11.97 TNF IL6 IL2RA IL1B GP5 CD8A
46
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 1
Show member pathways
 11.88 TNF IL2RA IL2 CXCL8
47
Pertussis 36
11.88 TNF TLR4 IL6 IL1B IL10 CXCL8
48
Innate Lymphoid Cell Differentiation Pathways 64
11.85 TNF IL2RA IL2 IL1B IL10 CD8A
49
Photodynamic therapy-induced NF-kB survival signaling 1
Show member pathways
 11.81 TNF IL6 IL2 IL1B CXCL8
50
IgA-Producing B Cells in the Intestine 64
11.81 TNF TLR9 TLR4 IL6 IL2RA IL10
Sources

GO Terms for Cervicitis

About this section

Cellular components related to Cervicitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 9.72 TNF TLR4 IL2RA CD8A CD4
2 extracellular region GO:0005576 9.7 TNF TLR9 SERPIND1 IL6 IL2 IL1B
3 cell surface GO:0009986 9.63 TNF TLR4 IL2RA HSPD1 GP6 CD4
4 extracellular space GO:0005615 9.36 TNF SERPIND1 MIR21 IL6 IL2 IL1B
5 lipopolysaccharide receptor complex GO:0046696 9.26 TLR4 HSPD1

Biological processes related to Cervicitis according to GeneCards Suite gene sharing:

(show top 50) (show all 72)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription by RNA polymerase II GO:0045944 10.27 TNF TLR9 TLR4 IL6 IL2 IL10
2 immune system process GO:0002376 10.22 TLR9 TLR4 IL2RA IL2 CD8A CD4
3 positive regulation of transcription, DNA-templated GO:0045893 10.2 TNF IL6 IL1B IL10 CDKN2A CD4
4 negative regulation of cell proliferation GO:0008285 10.12 MIR21 IL6 IL1B IL10 CXCL8 CDKN2A
5 positive regulation of apoptotic process GO:0043065 10.11 TNF MIR21 IL6 HSPD1 CDKN2A
6 positive regulation of gene expression GO:0010628 10.1 TNF TLR9 TLR4 MIR21 IL6 IL1B
7 inflammatory response GO:0006954 10.07 TNF TLR9 TLR4 IL6 IL2RA IL1B
8 positive regulation of ERK1 and ERK2 cascade GO:0070374 10.04 TNF TLR4 MIR21 CD4
9 defense response to bacterium GO:0042742 10.04 TNF TLR9 TLR4 IL10 DEFB4A DEFB103B
10 positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 10.03 TNF TLR9 TLR4 CD4
11 positive regulation of protein phosphorylation GO:0001934 10.03 TNF MIR21 IL2 IL1B CD4
12 response to lipopolysaccharide GO:0032496 10.01 TLR4 IL1B IL10 HSPD1
13 defense response GO:0006952 10 TNF DEFB4A DEFB103B CXCL8
14 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.99 TNF TLR9 TLR4 IL6 IL1B
15 positive regulation of DNA-binding transcription factor activity GO:0051091 9.97 TNF IL6 IL1B IL10
16 defense response to Gram-positive bacterium GO:0050830 9.96 TNF IL6 DEFB4A DEFB103B
17 positive regulation of JNK cascade GO:0046330 9.94 TNF TLR9 TLR4 IL1B
18 regulation of insulin secretion GO:0050796 9.92 TNF IL6 IL1B
19 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.92 TNF IL6 IL2
20 negative regulation of interleukin-6 production GO:0032715 9.92 TNF TLR9 TLR4